Sargent Bickham Lagudis LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Sargent Bickham Lagudis LLC

  • $1.22 Billion
  • Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 50 shares of XBI stock, worth $4,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$4,271
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
BUY
$76.72 - $85.66 $3,836 - $4,283
50 New
50 $0
Q2 2022

Jul 13, 2022
SELL
$62.81 - $96.09 $6,281 - $9,609
-100 Closed
0 $0
Q4 2020

May 24, 2021
BUY
$110.36 - $151.14 $1,655 - $2,267
15 Added 17.65%
100 $14,000
Q3 2020

Sep 01, 2021
BUY
$103.87 - $120.36 $2,077 - $2,407
20 Added 30.77%
85 $9,000
Q2 2020

Sep 07, 2021
BUY
$73.26 - $114.17 $2,197 - $3,425
30 Added 85.71%
65 $7,000
Q1 2020

Sep 07, 2021
BUY
$65.95 - $98.35 $2,308 - $3,442
35 New
35 $3,000
Q4 2018

Sep 13, 2021
SELL
N/A
-1,647 Closed
0 $0
Q1 2016

Sep 07, 2021
BUY
N/A
1,647
1,647 $85,000

Others Institutions Holding XBI

# of Institutions
801
Shares Held
111M
Call Options Held
22.4M
Put Options Held
28.8M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email